These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 8837586)
1. C-type natriuretic peptide-mediated coronary vasodilation: role of the coronary nitric oxide and particulate guanylate cyclase systems. Wright RS; Wei CM; Kim CH; Kinoshita M; Matsuda Y; Aarhus LL; Burnett JC; Miller WL J Am Coll Cardiol; 1996 Oct; 28(4):1031-8. PubMed ID: 8837586 [TBL] [Abstract][Full Text] [Related]
2. Relaxant effect of C-type natriuretic peptide involves endothelium and nitric oxide-cGMP system in rat coronary microvasculature. Brunner F; Wölkart G Cardiovasc Res; 2001 Aug; 51(3):577-84. PubMed ID: 11476748 [TBL] [Abstract][Full Text] [Related]
3. Further attenuation of endothelium-dependent relaxation imparted by natriuretic peptide receptor antagonism. Wennberg PW; Miller VM; Rabelink T; Burnett JC Am J Physiol; 1999 Oct; 277(4):H1618-21. PubMed ID: 10516202 [TBL] [Abstract][Full Text] [Related]
4. Endothelium-derived nitric oxide inhibits the relaxation of the porcine coronary artery to natriuretic peptides by desensitizing big conductance calcium-activated potassium channels of vascular smooth muscle. Liang CF; Au AL; Leung SW; Ng KF; Félétou M; Kwan YW; Man RY; Vanhoutte PM J Pharmacol Exp Ther; 2010 Jul; 334(1):223-31. PubMed ID: 20332186 [TBL] [Abstract][Full Text] [Related]
5. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708 [TBL] [Abstract][Full Text] [Related]
6. C-type natriuretic peptide-induced relaxation through cGMP-dependent protein kinase and SERCA activation is impaired in two kidney-one clip rat aorta. Pernomian L; do Prado AF; Silva BR; de Paula TD; Grando MD; Bendhack LM Life Sci; 2021 May; 272():119223. PubMed ID: 33610574 [TBL] [Abstract][Full Text] [Related]
7. Endothelial NO/cGMP system contributes to natriuretic peptide-mediated coronary and peripheral vasodilation. Brunner F; Wölkart G Microvasc Res; 2001 Jan; 61(1):102-10. PubMed ID: 11162200 [TBL] [Abstract][Full Text] [Related]
9. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs. Canty JM; Schwartz JS Circulation; 1994 Jan; 89(1):375-84. PubMed ID: 8281673 [TBL] [Abstract][Full Text] [Related]
10. Role for the endogenous natriuretic peptide system in the control of basal coronary vascular tone in dogs. Supaporn T; Wennberg PW; Wei CM; Kinoshita M; Matsuda Y; Burnett JC Clin Sci (Lond); 1996 May; 90(5):357-62. PubMed ID: 8665772 [TBL] [Abstract][Full Text] [Related]
11. C-type natriuretic peptide-induced vasodilation is dependent on hyperpolarization in human forearm resistance vessels. Honing ML; Smits P; Morrison PJ; Burnett JC; Rabelink TJ Hypertension; 2001 Apr; 37(4):1179-83. PubMed ID: 11304521 [TBL] [Abstract][Full Text] [Related]
12. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis. Shiode N; Morishima N; Nakayama K; Yamagata T; Matsuura H; Kajiyama G J Am Coll Cardiol; 1996 Feb; 27(2):304-10. PubMed ID: 8557898 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of relaxations to dendroaspis natriuretic peptide in canine coronary arteries. Collins E; Bracamonte MP; Burnett JC; Miller VM J Cardiovasc Pharmacol; 2000 Apr; 35(4):614-8. PubMed ID: 10774793 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of relaxations to C-type natriuretic peptide in veins. Banks M; Wei CM; Kim CH; Burnett JC; Miller VM Am J Physiol; 1996 Nov; 271(5 Pt 2):H1907-11. PubMed ID: 8945908 [TBL] [Abstract][Full Text] [Related]
15. CNP causes receptor-mediated positive dromotropic effects in anesthetized dog hearts. Hirose M; Furukawa Y; Miyashita Y; Kurogouchi F; Nakajima K; Tsuboi M; Chiba S Am J Physiol; 1998 Aug; 275(2):H717-20. PubMed ID: 9683463 [TBL] [Abstract][Full Text] [Related]
16. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations. Hirose M; Furukawa Y; Kurogouchi F; Nakajima K; Miyashita Y; Chiba S J Pharmacol Exp Ther; 1998 Jul; 286(1):70-6. PubMed ID: 9655843 [TBL] [Abstract][Full Text] [Related]
17. Preferential proximal coronary dilation by activators of guanylate cyclase in awake dogs. Chu A; Murray JJ; Lin CC; Russell M; Hagen PO; Cobb FR Am J Physiol; 1990 Aug; 259(2 Pt 2):H340-5. PubMed ID: 1974738 [TBL] [Abstract][Full Text] [Related]
18. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase. Rodriguez-Pascual F; Miras-Portugal MT; Torres M Mol Pharmacol; 1996 Jun; 49(6):1058-70. PubMed ID: 8649344 [TBL] [Abstract][Full Text] [Related]
19. Role of guanylate cyclase-cGMP systems in halothane-induced vasodilation in canine cerebral arteries. Eskinder H; Hillard CJ; Flynn N; Bosnjak ZJ; Kampine JP Anesthesiology; 1992 Sep; 77(3):482-7. PubMed ID: 1355637 [TBL] [Abstract][Full Text] [Related]
20. Differential relaxing responses to particulate or soluble guanylyl cyclase activation on endothelial cells: a mechanism dependent on PKG-I alpha activation by NO/cGMP. Rivero-Vilches FJ; de Frutos S; Saura M; Rodriguez-Puyol D; Rodriguez-Puyol M Am J Physiol Cell Physiol; 2003 Oct; 285(4):C891-8. PubMed ID: 12814915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]